Navigating Risk and Change - Day 1
Webinar
Advancing Regulatory Excellence in Excipient Equality and Single-Use Systems for Pharma Manufacturing
Session 1: Excipient Regulations for Drug Product Registration in China - Refresh and Update
In this session, you will learn:
- Refresh on introduction of China co-review system
- Update on ChP 2025 and China Excipient GMP requirement
- Summary and practical takeaway
Session 2: Excipients in Nitrosamine Risk Mitigation: Nitrite Control and Formulation Strategies
In this session, you will learn:
- Understanding the role of nitrites in excipients and their contribution to nitrosamine formation
- Explore current regulatory frameworks and their implications for pharmaceutical manufacturing
- Review drug formulation strategies for nitrosamine risk mitigation with excipients acting as scavengers for nitrosating agents or pH modifiers
Session 3: Update of Regulatory Requirements for EG/DEG in Pharmaceutical Products
In this session, you will learn:
- Background of DEG/EG – contaminated medicine and its impact
- Overview of global regulatory requirement
- What is our strategy and measurement to support customer’s evaluation.
Session 4: Single-Use Systems for Aseptic Manufacturing – Balancing Risks and Benefits
In this session, you will learn:
- How to ensure the integrity of a SUS, particularly after the sterile boundary
- Gain insights into SUS supplier assessment and what to expect.
- Recognize the importance of sterile connection devices as essential components when using SUS.
Speakers

Cloris Tian
Merck
Senior Regulatory Expert
Cloris is a Senior Regulatory Expert, China. She holds a Master’s degree in Biological Sciences and has over 20 years of experience in biologics R&D, product registration, and regulatory affairs across pharmaceuticals, excipients, food additives, chemicals, and life sciences. Cloris specializes in monitoring global regulations, strategic analysis, and regulatory training. She has served multiple terms on the IPEC Federation board and currently chairs IPEC China.

Dr. Ulrich Reichert, M.D.R.A.
Merck
Head of CDMO and Bioprocess Materials
Ulrich leads a global team supporting regulatory compliance for manufacturing active and biologic drug substances, including site registrations worldwide. With over 25 years of experience in regulatory and quality roles, he holds a PhD in Medicinal Chemistry and a Master in Drug Regulatory Affairs. Ulrich chairs the IPEC Europe Nitrosamine Task Force, participates in ICH and European Pharmacopoeia expert groups, and serves on the pharmacopoeia committee on medicinal chemistry at BfArM.

Yuwei Heinzel
Merck
Head of Pharma Registration
Yuwei holds a Master’s degree in Chemistry and Drug Regulatory Affairs and has nearly two decades of experience in the global registration of APIs, excipients, and drug products. She possesses deep regulatory expertise in GMP requirements for pharmaceutical raw materials and worldwide product registrations. She is an active member of the European APIC Working Group on Emerging Markets, M4Q(R2), the China Task Force, and the German Regulatory Affairs Association (DGRA).

Simone Biel, Ph.D.
Merck
Senior Regulatory Expert
Simone specializes in Single-Use Technology and filtration within biopharmaceutical manufacturing. She provides regulatory guidance to diverse stakeholders and has helped many drug manufacturers successfully implement Single-Use Technology. Her main focus is to ensure product performance meets quality and regulatory standards. Simone is an active member of the Parenteral Drug Association (PDA) and BioPhorum. She holds a Ph.D. in Microbiology from the University of Frankfurt.

Manisha Chaudhari
Merck
Head of Customer Applications-Excipient, APeC
Manisha Chaudhari is a pharmacist by education & has done Master of Pharmacy specialization in Drug Delivery technology from Institute of Chemical technology, Mumbai. She has more than 14 years of experience in the field of business development and technical marketing of excipients & API. Her areas of expertise include solubility & bioavailability enhancement.
Currently she is leading a team of Technical Application Experts, Excipients, APeC.

Kyung-Min Shin
Merck
Customer Application Consultant
Kyung-min Shin has over 20 years of experience in drug formulation research and marketing/customer applications. He has expertise in various pharmaceutical development areas, including New Chemical Entity (NCE) projects, Incrementally Modified Drugs (IMDs), and Co-development (C&D) projects. Currently, he works as a Customer Application Consultant, where he offers customized solutions for challenges in drug formulation development. He also advises on the selection of pharmaceutical raw materials for both classical and biopharmaceutical industries.

Bennett Tan
Merck
Regional Strategy Execution Manager
Bennett holds a Master of Chemical Engineering from Imperial College London and an MBA. He brings over a decade of expertise in business development, marketing, and partnership strategy. Since joined Merck Life Science in 2022, he has played a key role in developing and executing go-to-market strategies for single-use and integrated platform solutions in bioprocessing across APAC. Working with product managers, R&D and technical experts, he delivers tailored, innovative solutions that help biopharmaceutical customers accelerate development and delivery of life-saving therapies.
Pharma and biopharma manufacturing
- Classical pharma manufacturing
Duration:4h 3min
Language:English
Session 1:presented July 7, 2026